CN103990119A - 一种奶牛用电解质泡腾片及其应用 - Google Patents
一种奶牛用电解质泡腾片及其应用 Download PDFInfo
- Publication number
- CN103990119A CN103990119A CN201410204679.6A CN201410204679A CN103990119A CN 103990119 A CN103990119 A CN 103990119A CN 201410204679 A CN201410204679 A CN 201410204679A CN 103990119 A CN103990119 A CN 103990119A
- Authority
- CN
- China
- Prior art keywords
- electrolyte
- milch cow
- effervescent tablets
- parts
- dairy cattle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000283690 Bos taurus Species 0.000 title claims abstract description 123
- 239000007938 effervescent tablet Substances 0.000 title claims abstract description 82
- 239000003792 electrolyte Substances 0.000 title claims abstract description 76
- 235000013365 dairy product Nutrition 0.000 title abstract description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 51
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 48
- 238000002360 preparation method Methods 0.000 claims abstract description 37
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 36
- 239000000284 extract Substances 0.000 claims abstract description 32
- 239000001103 potassium chloride Substances 0.000 claims abstract description 24
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 24
- 239000011780 sodium chloride Substances 0.000 claims abstract description 24
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims abstract description 22
- 235000013336 milk Nutrition 0.000 claims abstract description 20
- 210000004080 milk Anatomy 0.000 claims abstract description 20
- 239000008267 milk Substances 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 235000017557 sodium bicarbonate Nutrition 0.000 claims abstract description 11
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims abstract description 11
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims description 36
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 35
- 241000411851 herbal medicine Species 0.000 claims description 32
- 239000003205 fragrance Substances 0.000 claims description 30
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 30
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 27
- 229960001031 glucose Drugs 0.000 claims description 27
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 17
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 235000019359 magnesium stearate Nutrition 0.000 claims description 15
- 239000004375 Dextrin Substances 0.000 claims description 14
- 229920001353 Dextrin Polymers 0.000 claims description 14
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 14
- 235000019425 dextrin Nutrition 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 229940088598 enzyme Drugs 0.000 claims description 12
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 12
- 239000003826 tablet Substances 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 10
- 238000007373 indentation Methods 0.000 claims description 10
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 10
- 108090000637 alpha-Amylases Proteins 0.000 claims description 9
- 229960004543 anhydrous citric acid Drugs 0.000 claims description 9
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 108090000145 Bacillolysin Proteins 0.000 claims description 6
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 6
- 108091005507 Neutral proteases Proteins 0.000 claims description 6
- 102000035092 Neutral proteases Human genes 0.000 claims description 6
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- 238000009413 insulation Methods 0.000 claims description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 6
- 239000007779 soft material Substances 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 5
- YERABYSOHUZTPQ-UHFFFAOYSA-P endo-1,4-beta-Xylanase Chemical compound C=1C=CC=CC=1C[N+](CC)(CC)CCCNC(C(C=1)=O)=CC(=O)C=1NCCC[N+](CC)(CC)CC1=CC=CC=C1 YERABYSOHUZTPQ-UHFFFAOYSA-P 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 102000013563 Acid Phosphatase Human genes 0.000 claims description 3
- 108010051457 Acid Phosphatase Proteins 0.000 claims description 3
- 108091005508 Acid proteases Proteins 0.000 claims description 3
- 108010004032 Bromelains Proteins 0.000 claims description 3
- 108010015776 Glucose oxidase Proteins 0.000 claims description 3
- 239000004367 Lipase Substances 0.000 claims description 3
- 102000004882 Lipase Human genes 0.000 claims description 3
- 108090001060 Lipase Proteins 0.000 claims description 3
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims description 3
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 3
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 3
- 102000004139 alpha-Amylases Human genes 0.000 claims description 3
- 229940024171 alpha-amylase Drugs 0.000 claims description 3
- 108010019077 beta-Amylase Proteins 0.000 claims description 3
- 235000019835 bromelain Nutrition 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 230000002538 fungal effect Effects 0.000 claims description 3
- 235000019420 glucose oxidase Nutrition 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- 235000019421 lipase Nutrition 0.000 claims description 3
- 239000010271 massa medicata fermentata Substances 0.000 claims description 3
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 230000007480 spreading Effects 0.000 claims description 3
- 238000003892 spreading Methods 0.000 claims description 3
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 claims description 2
- 101710130006 Beta-glucanase Proteins 0.000 claims description 2
- 239000004366 Glucose oxidase Substances 0.000 claims description 2
- 239000009636 Huang Qi Substances 0.000 claims description 2
- 102000006995 beta-Glucosidase Human genes 0.000 claims description 2
- 108010047754 beta-Glucosidase Proteins 0.000 claims description 2
- 229940116332 glucose oxidase Drugs 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 238000012423 maintenance Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 13
- 238000004519 manufacturing process Methods 0.000 abstract description 11
- 206010014418 Electrolyte imbalance Diseases 0.000 abstract description 10
- 244000309466 calf Species 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 9
- 238000010521 absorption reaction Methods 0.000 abstract description 7
- 230000029087 digestion Effects 0.000 abstract description 7
- 235000019629 palatability Nutrition 0.000 abstract description 5
- 230000001850 reproductive effect Effects 0.000 abstract description 5
- 230000009984 peri-natal effect Effects 0.000 abstract description 2
- 230000032696 parturition Effects 0.000 abstract 3
- 230000003247 decreasing effect Effects 0.000 abstract 2
- 235000013312 flour Nutrition 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 34
- 201000010099 disease Diseases 0.000 description 26
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 26
- -1 because having Chemical compound 0.000 description 17
- 230000003203 everyday effect Effects 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 239000012530 fluid Substances 0.000 description 8
- 238000001802 infusion Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 230000018044 dehydration Effects 0.000 description 7
- 238000006297 dehydration reaction Methods 0.000 description 7
- 229910001414 potassium ion Inorganic materials 0.000 description 7
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 235000015165 citric acid Nutrition 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 230000002354 daily effect Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000006651 lactation Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 108060003951 Immunoglobulin Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 102000018358 immunoglobulin Human genes 0.000 description 4
- 238000010253 intravenous injection Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 229910001415 sodium ion Inorganic materials 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000019025 Hypokalemia Diseases 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 238000009360 aquaculture Methods 0.000 description 3
- 244000144974 aquaculture Species 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 241000511730 Leymus chinensis Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000282849 Ruminantia Species 0.000 description 2
- 208000010513 Stupor Diseases 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 210000003022 colostrum Anatomy 0.000 description 2
- 235000021277 colostrum Nutrition 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000002977 intracellular fluid Anatomy 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 208000024896 potassium deficiency disease Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000004460 silage Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- DVWJFTGEISXVSH-CWVFEVJCSA-N (1R,3S,5S,7Z,11R,12S,13Z,15Z,17Z,19Z,21R,23S,24R,25S)-21-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-12-ethyl-1,3,5,25-tetrahydroxy-11-methyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid Chemical compound CC[C@H]1\C=C/C=C\C=C/C=C\[C@@H](C[C@@H]2O[C@@](O)(C[C@H](O)[C@H]2C(O)=O)C[C@@H](O)C[C@@H](O)C\C=C/C(=O)O[C@@H]1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N)[C@@H]1O DVWJFTGEISXVSH-CWVFEVJCSA-N 0.000 description 1
- UIFGGABIJBWRMG-FMQUCBEESA-N (4-chlorophenyl)methyl (ne)-n-[(4-chlorophenyl)methoxycarbonylimino]carbamate Chemical compound C1=CC(Cl)=CC=C1COC(=O)\N=N\C(=O)OCC1=CC=C(Cl)C=C1 UIFGGABIJBWRMG-FMQUCBEESA-N 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 108700038091 Beta-glucanases Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 101710089042 Demethyl-4-deoxygadusol synthase Proteins 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 229940079172 Osmotic diuretic Drugs 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000208966 Polygala Species 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 241000545442 Radix Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000001981 hip bone Anatomy 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000002239 ischium bone Anatomy 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002337 osmotic diuretic agent Substances 0.000 description 1
- 229960004368 oxytetracycline hydrochloride Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 210000003019 respiratory muscle Anatomy 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-N sodium;hydron;carbonate Chemical compound [Na+].OC(O)=O UIIMBOGNXHQVGW-UHFFFAOYSA-N 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 208000014221 sudden cardiac arrest Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229930183279 tetramycin Natural products 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
分值 | 脊椎部 | 肋部 | 臀部两侧 | 尾根两侧 | 髋骨、坐骨关节 |
1 | 非常突出 | 根根可见 | 严重下陷 | 隐窝很深 | 非常突出 |
2 | 明显突出 | 多数可见 | 明显下陷 | 隐窝明显 | 明显突出 |
3 | 稍微突出 | 少数可见 | 稍微下陷 | 隐窝稍显 | 稍微突出 |
4 | 平直 | 完全不见 | 平直 | 隐窝不显 | 不显示突出 |
5 | 丰满 | 丰满 | 丰满 | 丰满 | 丰满 |
头数(头) | 产奶天数(天) | 总产奶量(kg) | 平均产奶量(kg/天.头) | |
对照组 | 30 | 300 | 8528 | 28.42±5.16 |
试验组 | 30 | 300 | 10232 | 34.11±5.92 |
处理差异b | 5.69 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410204679.6A CN103990119B (zh) | 2014-05-15 | 2014-05-15 | 一种奶牛用电解质泡腾片及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410204679.6A CN103990119B (zh) | 2014-05-15 | 2014-05-15 | 一种奶牛用电解质泡腾片及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103990119A true CN103990119A (zh) | 2014-08-20 |
CN103990119B CN103990119B (zh) | 2016-04-20 |
Family
ID=51304616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410204679.6A Active CN103990119B (zh) | 2014-05-15 | 2014-05-15 | 一种奶牛用电解质泡腾片及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103990119B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106045696A (zh) * | 2016-06-03 | 2016-10-26 | 嘉兴德扬生物科技有限公司 | 一种水仙花专用的营养肥料泡腾片 |
CN107047996A (zh) * | 2017-06-19 | 2017-08-18 | 佛山市南海东方澳龙制药有限公司 | 奶牛产后营养强化速补剂及其制备方法 |
CN110038029A (zh) * | 2019-02-22 | 2019-07-23 | 王允瑞 | 一种动物用口服补液盐泡腾片及其制备方法 |
CN114027258A (zh) * | 2021-11-29 | 2022-02-11 | 重庆市大足区瑞丰现代农业发展有限公司 | 一种黑山羊的有机养殖方法 |
CN114304386A (zh) * | 2021-12-28 | 2022-04-12 | 厦门惠盈动物科技有限公司 | 一种植物源活性成分和矿物元素组合的液态饲料添加剂及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102133206A (zh) * | 2011-03-21 | 2011-07-27 | 郑州百瑞动物药业有限公司 | 一种奶牛用盐酸土霉素泡腾片及其制备方法 |
CN103638069A (zh) * | 2013-11-14 | 2014-03-19 | 长春博瑞饲料集团有限公司 | 一种治疗犊牛腹泻的电解质补充剂及其使用方法 |
-
2014
- 2014-05-15 CN CN201410204679.6A patent/CN103990119B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102133206A (zh) * | 2011-03-21 | 2011-07-27 | 郑州百瑞动物药业有限公司 | 一种奶牛用盐酸土霉素泡腾片及其制备方法 |
CN103638069A (zh) * | 2013-11-14 | 2014-03-19 | 长春博瑞饲料集团有限公司 | 一种治疗犊牛腹泻的电解质补充剂及其使用方法 |
Non-Patent Citations (1)
Title |
---|
袁中标等: "电解质在养牛生产中的应用", 《饲料博览》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106045696A (zh) * | 2016-06-03 | 2016-10-26 | 嘉兴德扬生物科技有限公司 | 一种水仙花专用的营养肥料泡腾片 |
CN107047996A (zh) * | 2017-06-19 | 2017-08-18 | 佛山市南海东方澳龙制药有限公司 | 奶牛产后营养强化速补剂及其制备方法 |
CN107047996B (zh) * | 2017-06-19 | 2020-04-07 | 佛山市南海东方澳龙制药有限公司 | 奶牛产后营养强化速补剂及其制备方法 |
CN110038029A (zh) * | 2019-02-22 | 2019-07-23 | 王允瑞 | 一种动物用口服补液盐泡腾片及其制备方法 |
CN114027258A (zh) * | 2021-11-29 | 2022-02-11 | 重庆市大足区瑞丰现代农业发展有限公司 | 一种黑山羊的有机养殖方法 |
CN114304386A (zh) * | 2021-12-28 | 2022-04-12 | 厦门惠盈动物科技有限公司 | 一种植物源活性成分和矿物元素组合的液态饲料添加剂及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103990119B (zh) | 2016-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103976190B (zh) | 猪饲料及其应用 | |
CN103960548B (zh) | 一种妊娠母猪的饲喂方法 | |
CN102246909B (zh) | 一种围产期奶牛专用保健饲料及其制备方法 | |
CN103990119B (zh) | 一种奶牛用电解质泡腾片及其应用 | |
CN105707875B (zh) | 一种红黑枸杞含片及其制备方法 | |
CN103349323A (zh) | 一种葛根解酒饮料的配方 | |
CN103947904B (zh) | 一种改善奶牛瘤胃菌群葡萄糖前体物的制备方法 | |
CN106036429A (zh) | 一种用于减肥的保健品及其制备方法 | |
CN103948916A (zh) | 一种奶牛用电解质泡腾片的制备方法 | |
CN104000038B (zh) | 一种改善奶牛瘤胃菌群的葡萄糖前体物及其应用 | |
CN106306533A (zh) | 一种防治鸡传染性支气管炎的中药饲料及制备方法 | |
CN109662253A (zh) | 一种具有食疗功能的面条及其制备方法 | |
CN106071366A (zh) | 一种中药发酵多酶促生长的鳜鱼饲料 | |
CN105995179A (zh) | 一种蛋鸡育成期中药饲料添加剂的制备方法 | |
CN106420955A (zh) | 具有辅助降血糖功效的中药组合物及其制备方法和产品 | |
CN106036152A (zh) | 一种蛋鸡产蛋前期饲料的制备方法 | |
CN102424792B (zh) | 哈士蟆月子酒及其配制方法 | |
CN101491629B (zh) | 一种治疗糖尿病的药物组合物及其制备方法 | |
CN106857846A (zh) | 二十三种叶蛋白特殊医学用途配方食品 | |
CN103960486B (zh) | 一种用于生产保健蛋的禽类饲料添加剂 | |
CN102885364A (zh) | 一种玉米饮料及其制备方法 | |
CN106551225A (zh) | 一种饮料及其制备方法 | |
CN106036171A (zh) | 一种蛋鸡育成期饲料的制备方法 | |
CN104587175A (zh) | 一种治疗糖尿病的中药配方 | |
CN104643198A (zh) | 一种西洋参饮品及其生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Electrolyte effervescent tablet for dairy cattle and application thereof Effective date of registration: 20181122 Granted publication date: 20160420 Pledgee: Beijing technology intellectual property financing Company limited by guarantee Pledgor: Beijing Eastern Bell Technology Co., Ltd. Registration number: 2018990001102 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20191126 Granted publication date: 20160420 Pledgee: Beijing technology intellectual property financing Company limited by guarantee Pledgor: Beijing Eastern Bell Technology Co., Ltd. Registration number: 2018990001102 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Electrolyte effervescent tablet for dairy cattle and application thereof Effective date of registration: 20191126 Granted publication date: 20160420 Pledgee: Beijing technology intellectual property financing Company limited by guarantee Pledgor: Beijing Eastern Bell Technology Co., Ltd. Registration number: Y2019990000586 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201221 Granted publication date: 20160420 Pledgee: Beijing technology intellectual property financing Company limited by guarantee Pledgor: BEIJING EASTERN BELL TECHNOLOGY Co.,Ltd. Registration number: Y2019990000586 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210601 Address after: 7012-26, 7th floor, intelligent R & D building, Suyin Industrial Park, Yinchuan City, Ningxia Hui Autonomous Region Patentee after: Dongfang Lianming (Ningxia) Technology Development Co.,Ltd. Address before: 100085 21-d, building 2, No.2, Shangdi Information Road, Haidian District, Beijing Patentee before: BEIJING EASTERN BELL TECHNOLOGY Co.,Ltd. |